Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2025-12-30 @ 3:47 AM
Study NCT ID:
NCT04141995
Status:
TERMINATED
Last Update Posted:
2025-08-07
First Post:
2019-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
Sponsor:
University of Nebraska
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-13
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-18
First Submit QC Date:
None
Study First Post Date:
2019-10-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-02
Last Update Post Date:
2025-08-07
Last Update Post Date Type:
ACTUAL